Literature DB >> 18812213

Magnesium treatment and spontaneous mild hypothermia after transient focal cerebral ischemia in the rat.

Kym Campbell1, Bruno P Meloni, Hongdong Zhu, Neville W Knuckey.   

Abstract

There is evidence from global cerebral ischemia experiments in the rat that the neuroprotection attributable to magnesium treatment depends on the concurrent presence of at least mild hypothermia. We set out to determine to what extent spontaneous hypothermia occurred after transient middle cerebral artery occlusion in the rat, and whether this hypothermia influenced the outcome of magnesium treatment. We found that rectal temperatures from 30 min to 3h after recovery from anaesthesia/surgery were 1 °C lower than in the period from 4 to 6h. Striatal infarcts were significantly reduced by 32% in animals treated with 360 μmol/kg MgSO(4) intravenously immediately prior to ischemia. A higher magnesium dose of 720 μmol/kg had not effect on infarct volume. Having previously established that these two doses of magnesium are ineffective in normothermic animals using this model, we conclude that the mild spontaneous hypothermia contributed to the observed neuroprotective effect of magnesium in this study, and that previous studies of magnesium in cerebral ischemia have likely been confounded in this way.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812213     DOI: 10.1016/j.brainresbull.2008.08.017

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Incidence, hemodynamic, and electrical characteristics of spreading depolarization in a swine model are affected by local but not by intravenous application of magnesium.

Authors:  Edgar Santos; Fiorella León; Humberto Silos; Renan Sanchez-Porras; C William Shuttleworth; Andreas Unterberg; Oliver W Sakowitz
Journal:  J Cereb Blood Flow Metab       Date:  2016-09-28       Impact factor: 6.200

2.  Electrochemical deposition and evaluation of electrically conductive polymer coating on biodegradable magnesium implants for neural applications.

Authors:  Meriam A Sebaa; Shan Dhillon; Huinan Liu
Journal:  J Mater Sci Mater Med       Date:  2012-10-27       Impact factor: 3.896

Review 3.  Magnesium: potential roles in neurovascular disease.

Authors:  Jason J Chang; William J Mack; Jeffrey L Saver; Nerses Sanossian
Journal:  Front Neurol       Date:  2014-04-15       Impact factor: 4.003

4.  The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.

Authors:  D Milani; N W Knuckey; R S Anderton; J L Cross; B P Meloni
Journal:  Stroke Res Treat       Date:  2016-05-10

5.  Allopregnanolone and its precursor progesterone do not reduce injury after experimental stroke in hypertensive rats - role of postoperative temperature regulation?

Authors:  Neil J Spratt; Amelia J Tomkins; Debbie Pepperall; Damian D McLeod; Mike B Calford
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

6.  Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.

Authors:  Diego Milani; Vince W Clark; Jane L Cross; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  BMC Neurosci       Date:  2016-05-03       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.